Research ArticleNeurology
Preclinical Development of 18F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis
Hazem Ahmed, Rahel Wallimann, Ahmed Haider, Vahid Hosseini, Stefan Gruber, Marvin Robledo, Thi A.N. Nguyen, Adrienne Müller Herde, Irina Iten, Claudia Keller, Viola Vogel, Roger Schibli, Bernhard Wünsch, Linjing Mu and Simon M. Ametamey
Journal of Nuclear Medicine February 2021, 62 (2) 259-265; DOI: https://doi.org/10.2967/jnumed.120.246785
Hazem Ahmed
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Rahel Wallimann
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Ahmed Haider
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Vahid Hosseini
2Laboratory of Applied Mechanobiology, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland
Stefan Gruber
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Marvin Robledo
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Thi A.N. Nguyen
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Adrienne Müller Herde
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Irina Iten
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Claudia Keller
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Viola Vogel
2Laboratory of Applied Mechanobiology, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zürich, Zurich, Switzerland
Roger Schibli
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
3Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland; and
Bernhard Wünsch
4Institute of Pharmaceutical and Medicinal Chemistry, University of Münster, Münster, Germany
Linjing Mu
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
3Department of Nuclear Medicine, University Hospital Zurich, Zurich, Switzerland; and
Simon M. Ametamey
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 2
February 1, 2021
Preclinical Development of 18F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis
Hazem Ahmed, Rahel Wallimann, Ahmed Haider, Vahid Hosseini, Stefan Gruber, Marvin Robledo, Thi A.N. Nguyen, Adrienne Müller Herde, Irina Iten, Claudia Keller, Viola Vogel, Roger Schibli, Bernhard Wünsch, Linjing Mu, Simon M. Ametamey
Journal of Nuclear Medicine Feb 2021, 62 (2) 259-265; DOI: 10.2967/jnumed.120.246785
Preclinical Development of 18F-OF-NB1 for Imaging GluN2B-Containing N-Methyl-d-Aspartate Receptors and Its Utility as a Biomarker for Amyotrophic Lateral Sclerosis
Hazem Ahmed, Rahel Wallimann, Ahmed Haider, Vahid Hosseini, Stefan Gruber, Marvin Robledo, Thi A.N. Nguyen, Adrienne Müller Herde, Irina Iten, Claudia Keller, Viola Vogel, Roger Schibli, Bernhard Wünsch, Linjing Mu, Simon M. Ametamey
Journal of Nuclear Medicine Feb 2021, 62 (2) 259-265; DOI: 10.2967/jnumed.120.246785